FOR IMMEDIATE RELEASE: Solulink Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody‐Labeling Technology

First Page		Document Content
Date: 2013-07-17 13:36:02 Immune system Clinical pathology Flow cytometry Antibody FluoProbes Biology Medicine Laboratory techniques		FOR IMMEDIATE RELEASE: Solulink Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody‐Labeling Technology Add to Reading List Source URL: www.solulink.com Download Document from Source Website File Size: 132,13 KB Share Document on Facebook

	DOC Document DocID: 1owxr - View Document
	FOR IMMEDIATE RELEASE: Solulink Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody‐Labeling Technology DocID: 8SWC - View Document
	FluoProbes® FT-46540A DocID: 2l5k - View Document
	InterBioTech FT-CL0731 DocID: 2l5h - View Document
	FluoProbes® FT-M1473A DocID: 2l5c - View Document